Original Research

Accepted on 07 May 2024

Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: A Children's Oncology Group report

in Cardio-Oncology

Kasey J Leger
Michael J Absalon
Biniyam Demissei
Amanda M Smith
Robert Gerbing
Todd Alonzo
Hari Narayan
Betsy A Hirsch
Jessica Pollard
Bassem I Razzouk

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1347547

Case Report

Accepted on 06 May 2024

Case Report: Assessment of Primary Myxofibrosarcoma in the Left Atrium using Multimodal Ultrasonography

in Cardio-Oncology

Liyan Hu
Zhaohui Wang
Yu Chen
Xiaowei Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1378655

Original Research

Published on 25 Apr 2024

Thyroid cancer and cardiovascular diseases: a Mendelian randomization study

in Cardio-Oncology

Yamei Gao
Zhijia Wang
Jinsheng Yu
Lijun Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1344515

388 views

Original Research

Accepted on 09 Apr 2024

Sodium-glucose cotransporter 2 inhibitor Dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity

in Cardio-Oncology

Vincenzo Quagliariello
Maria Laura Canale
Irma Bisceglia
Martina Iovine
Andrea Paccone
Carlo Maurea
Marino Scherillo
Alessia Merola
Vienna Giordano
Giuseppe Palma

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1289663

Original Research

Published on 04 Apr 2024

Prevalence and outcomes of atrial fibrillation in patients suffering prostate cancer: a national analysis in the United States

in Cardio-Oncology

Zhemin Pan
Xiao Xu
Xi Xu
Shengyong Wu
Zhensheng Zhang
Suxuan Liu
Zhijian Liu
Boxiang Tu
Chenxin Chen
Yingyi Qin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1382166

576 views

Case Report

Published on 22 Mar 2024

Case Report: Two cases of advanced primary cardiac angiosarcoma treated with anlotinib and a retrospective analysis of the literature

in Cardio-Oncology

Pan Yang
Fu Xiong
Bingjing Zhu
Liang Gong
Chunlan Tang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1363235

746 views

Original Research

Published on 21 Mar 2024

Exploring the effects of calycosin on anthracycline-induced cardiotoxicity: a network pharmacology, molecular docking, and experimental study

in Cardio-Oncology

Peng Zhu
Qianqian Ren
Ruizhi Zhang
Licai Zhang
Xiangwen Xia
Chuansheng Zheng
Tianhe Ye

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1286620

1,006 views

Editorial

Published on 06 Mar 2024

Editorial: Interpretable predictive analytics for precision cardio-oncology preventive care

in Cardio-Oncology

Jiandong Zhou
Tong Liu
Leonardo Roever
Qingpeng Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1377749

706 views

Case Report

Published on 29 Feb 2024

Navigating P2Y12 inhibition in the labyrinth of cardio-oncology care: cangrelor bridging in patients with cancer

in Cardio-Oncology

Abdelrahman Ali
Poonam Jewani
Max Bourdillon
Efstratios Koutroumpakis
Shaden Khalaf
Konstantinos Charitakis
Kara Thompson
Konstantinos Marmagkiolis
Anita Deswal
Cezar Iliescu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1337957

1,450 views

Case Report

Published on 28 Feb 2024

Case Report: A case of third-degree atrioventricular block associated with primary cardiac lymphoma

in Cardio-Oncology

Jianping Liu
Yong Zheng
Weishan Zhang
Juan Xia
Yongheng Zhang
Long Tang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1356134

921 views

Case Report

Published on 19 Feb 2024

Case Report: Sudden very late-onset near fatal PD1 inhibitor-associated myocarditis with out-of-hospital cardiac arrest after >2.5 years of pembrolizumab treatment

in Cardio-Oncology

Richard I. Lewis
Katharina Seuthe
Simon Lennartz
Jan-Phillip Weber
Nicole Kreuzberg
Karin Klingel
Paul J. Bröckelmann

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1328378

1,334 views
1 citation

Clinical Trial

Published on 07 Feb 2024

A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin

in Cardio-Oncology

Shinjeong Song
Joohyun Woo
HyunGoo Kim
Jun Woo Lee
Woosung Lim
Byung-In Moon
Kihwan Kwon

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1324203

641 views

Systematic Review

Published on 02 Feb 2024

Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis

in Cardio-Oncology

Alessandro Inno
Antonello Veccia
Giorgio Madonia
Alvise Berti
Roberto Bortolotti
Lorena Incorvaia
Antonio Russo
Orazio Caffo
Stefania Gori

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1309100

1,574 views

Original Research

Published on 23 Jan 2024

Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology

in Cardio-Oncology

V. Quagliariello
M. Passariello
I. Bisceglia
A. Paccone
A. Inno
C. Maurea
R. Rapuano Lembo
L. Manna
M. Iovine
M. L. Canale

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1232269

1,845 views
1 citation

Original Research

Published on 19 Jan 2024

Features of trastuzumab-related cardiac dysfunction: deformation analysis outside left ventricular global longitudinal strain

in Cardio-Oncology

Giang M. Nhat
Nguyen H. Hai
Vo T. Duc
Ho H. Q. Tri
Chau N. Hoa

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1291180

1,105 views

Case Report

Published on 18 Jan 2024

Case Report: Carcinoid heart disease with severe tricuspid regurgitation and concomitant patent foramen ovale causing severe hypoxia

in Cardio-Oncology

Michael Cronin
Brendan McAdam

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1309929

774 views

Navigation group

Articles

Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: A Children's Oncology Group report

Case Report: Assessment of Primary Myxofibrosarcoma in the Left Atrium using Multimodal Ultrasonography

Thyroid cancer and cardiovascular diseases: a Mendelian randomization study

Sodium-glucose cotransporter 2 inhibitor Dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity

Prevalence and outcomes of atrial fibrillation in patients suffering prostate cancer: a national analysis in the United States

Case Report: Two cases of advanced primary cardiac angiosarcoma treated with anlotinib and a retrospective analysis of the literature

Exploring the effects of calycosin on anthracycline-induced cardiotoxicity: a network pharmacology, molecular docking, and experimental study

Editorial: Interpretable predictive analytics for precision cardio-oncology preventive care

Navigating P2Y12 inhibition in the labyrinth of cardio-oncology care: cangrelor bridging in patients with cancer

Case Report: A case of third-degree atrioventricular block associated with primary cardiac lymphoma

Case Report: Sudden very late-onset near fatal PD1 inhibitor-associated myocarditis with out-of-hospital cardiac arrest after >2.5 years of pembrolizumab treatment

A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin

Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis

Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology

Features of trastuzumab-related cardiac dysfunction: deformation analysis outside left ventricular global longitudinal strain

Case Report: Carcinoid heart disease with severe tricuspid regurgitation and concomitant patent foramen ovale causing severe hypoxia